MaaT Pharma(FR:MAAT)
€1.06-0.01 (-0.93%)
FR:MAAT
MaaT Pharma financials statements
€1.06
At close:-0.01 (-0.93%)
Want to see FR:MAAT full AI Analyst Report?
MaaT Pharma (MAAT) Income Statement
4 Followers
MaaT Pharma Income Statement
Last quarter (Q2 2026), MaaT Pharma's total revenue was €1.08M, a decrease of 37.30% from the same quarter last year. In Q2, MaaT Pharma's net income was €-18.33M. See MaaT Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 4.52M | € 3.22M | € 2.23M | € 1.43M | € 972.00K | |
| € 1.39M | € 1.97M | € 784.00K | € 1.09M | € 806.00K | |
| € 35.54M | € 30.39M | € 25.39M | € 14.65M | € 9.70M | |
| Depreciation and Amortization | € 1.74M | € 1.69M | € 871.00K | € 429.00K | € 328.00K |
| € -32.41M | € -26.34M | € -22.07M | € -13.10M | € -8.57M | |
| € -34.15M | € -28.43M | € -19.94M | € -13.56M | € -8.89M | |
| € -705.00K | € -3.99M | € 226.00K | € -156.00K | € -126.00K | |
| € -34.85M | € -32.42M | € -19.72M | € -13.71M | € -9.02M | |
| € -31.06M | € -28.90M | € -19.72M | € -13.71M | € -9.02M | |
| Per Share Metrics | |||||
| Basic EPS | € -1.95 | € -2.20 | € -1.73 | € -1.39 | € -3.72 |
| Diluted EPS | € -1.95 | € -2.20 | € -1.73 | € -1.39 | € -3.72 |
| Weighted Average Shares Outstanding | 15.93M | 13.06M | 11.37M | 9.89M | 2.43M |
| Weighted Average Shares Outstanding (Diluted) | 15.93M | 13.06M | 11.37M | 9.89M | 2.43M |
Currency in EUR
